To further assess the link between high lysyl oxidase family expression and pancreatic cancer, we analyzed biobanked plasma from 12 patients with histologically confirmed PDAC (stage III and IV) and 30 age- and sex-matched healthy individuals with no clinical diagnosis of disease, for LOX and LOXL2. Here, LOXL2 is linked to familial pancreatic carcinoma.